ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Psychiatry

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,785Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 465

$1.56M Total Retail Price of All Prescriptions

Rank: 3 out of 465

878 Patients Receiving at Least One Drug in Part D
18% Patients 65 Years and Older
73% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in North Carolina
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

8% of this provider’s 878 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

3% of this provider’s 878 patients filled at least one prescription for a schedule three drug, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$106 was the average price of a prescription from this provider, compared to $116 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
ALPRAZOLAM 1,415 306 202 B 1 3
TRAZODONE HCL 870 130 211 2 2
CLONAZEPAM 600 165 104 B 3 1
BENZTROPINE MESYLATE 481 59 143 R 4 7
QUETIAPINE FUMARATE 480 118 106 A 5 4
LAMOTRIGINE 479 48 88 6 6
CITALOPRAM HBR 449 58 109 7 14
BUPROPION XL 433 90 99 8 17
RISPERIDONE 433 84 99 A 8 5
CYMBALTA 420 86 98 10 10
ZOLPIDEM TARTRATE 413 79 79 11 12
FLUOXETINE HCL 368 71 66 12 13
LORAZEPAM 335 102 66 B 13 9
ABILIFY 328 74 79 A 14 11
SERTRALINE HCL 317 88 67 15 8
DIVALPROEX SODIUM ER 314 49 66 16 18
GABAPENTIN 292 77 89 17 22
VENLAFAXINE HCL ER 274 80 55 18 20
OLANZAPINE 271 49 49 A 19 16
DIAZEPAM 271 28 56 B 19 23
SEROQUEL XR 247 15 45 A 21 30
ESCITALOPRAM OXALATE 235 91 43 22 19
BUSPIRONE HCL 217 61 60 23 27
LITHIUM CARBONATE 203 28 54 24 21
PRISTIQ ER 195 17 37 25 38
PAROXETINE HCL 188 54 38 26 28
DIVALPROEX SODIUM 166 49 43 27 34
MIRTAZAPINE 157 40 38 28 15
TOPIRAMATE 150 <11 35 29 35
AMPHETAMINE SALT COMBO 149 12 21 S2 30 32
ZIPRASIDONE HCL 137 <11 31 A 31 26
HYDROXYZINE PAMOATE 125 <11 39 R 32 33
BUPROPION HCL SR 122 32 24 33 29
TEMAZEPAM 113 33 25 B 34 39
PERPHENAZINE 108 25 27 A 35 56
OXCARBAZEPINE 104 <11 31 36 50
ROPINIROLE HCL 85 21 21 37 80
AMITRIPTYLINE HCL 82 14 23 R 38 43
SAPHRIS 71 0 23 A 39 68
DONEPEZIL HCL 69 35 12 40 44
CHLORPROMAZINE HCL 65 0 15 A 41 52
PROPRANOLOL HCL 64 14 14 42 45
INVEGA SUSTENNA 62 0 16 A 43 31
OMEPRAZOLE 58 <11 28 44 54
HALOPERIDOL 58 <11 20 A 44 24
LATUDA 56 0 15 A 46 41
CLOZAPINE 53 <11 <11 A 47 25
THIOTHIXENE 52 12 21 A 48 72
FLUPHENAZINE HCL 51 17 15 A 49 42
INVEGA 51 <11 <11 A 49 48
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 18, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.